GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Pre-Tax Income

China National Medicines (SHSE:600511) Pre-Tax Income : ¥2,970 Mil (TTM As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is China National Medicines Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. China National Medicines's pretax income for the three months ended in Mar. 2024 was ¥614 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,970 Mil. China National Medicines's pretax margin was 5.06%.

During the past 13 years, China National Medicines's highest Pretax Margin was 5.91%. The lowest was 4.54%. And the median was 5.34%.


China National Medicines Pre-Tax Income Historical Data

The historical data trend for China National Medicines's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Medicines Pre-Tax Income Chart

China National Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,426.56 1,917.35 2,444.81 2,687.89 2,930.89

China National Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 574.09 750.42 661.55 944.84 613.54

Competitive Comparison of China National Medicines's Pre-Tax Income

For the Medical Distribution subindustry, China National Medicines's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Medicines's Pre-Tax Income Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Medicines's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where China National Medicines's Pre-Tax Income falls into.



China National Medicines Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

China National Medicines's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=2457.155+0+-31.57+166.372+338.933
=2,931

China National Medicines's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=512.989+0+-7.317+-39.711+147.575
=614

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,970 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China National Medicines  (SHSE:600511) Pre-Tax Income Explanation

China National Medicines's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=613.536/12122.143
=5.06%

During the past 13 years, China National Medicines's highest Pretax Margin was 5.91%. The lowest was 4.54%. And the median was 5.34%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China National Medicines Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of China National Medicines's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Medicines (SHSE:600511) Business Description

Traded in Other Exchanges
N/A
Address
No. 12 A, Sanyuan West Lane, Yongwai, Chongwen District, Beijing, CHN, 100077
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.
Executives
Chen Zhang Qing Director

China National Medicines (SHSE:600511) Headlines

No Headlines